Watch a replay of the HPS Corporate Lending Fund Second Quarter 2026 Shareholder Update Webcast

Click Here

Portfolio

Portfolio Companies89

Clear Filters
Company Name
Industry
Investment Type
Reference Rate & Spread11
Par Amount (thousands)
Amortized Cost (thousands)
Fair Value (thousands)
% of Total Portfolio
2080 Media, Inc. (PlayOn Sports) Media 1st Lien Senior Secured Debt S + 4.75% $112,491 87,096 87,671 0.38%
AS1 Sports Bidco Ltd Media 1st Lien Senior Secured Debt E + 5.50% €20,191 22,037 21,613 0.09%
LOCI Bidco Limited (Law Business Research) Media 1st Lien Senior Secured Debt SN + 5.25% £52,719 65,838 70,628 0.31%
LOCI Bidco Limited (Law Business Research) Media 1st Lien Senior Secured Debt S + 5.25% $8,667 8,519 8,611 0.04%
OneTeam Partners, LLC (OneTeam Partners) Media Preferred Equity 8.00% $947 947 1,269 0.01%
Indicor LLC (Indicor) Machinery 1st Lien Senior Secured Debt S + 2.50% $20,242 19,940 20,279 0.09%
LSF12 Donnelly Bidco, LLC (Carlisle Fluid) Machinery 1st Lien Senior Secured Debt S + 6.50% $18,411 18,167 18,411 0.08%
Lsf12 Helix Parent LLC (Hillenbrand) Machinery 1st Lien Senior Secured Debt S + 3.50% $17,352 16,900 17,188 0.07%
Radwell Parent, LLC Machinery 1st Lien Senior Secured Debt S + 4.75% $155,715 141,851 143,165 0.62%
Rotation Buyer, LLC (Rotating Machinery Services Inc) Machinery 1st Lien Senior Secured Debt S + 4.75% $91,448 73,234 69,029 0.30%
TK Elevator US Newco Inc (TK Elevator) Machinery 1st Lien Senior Secured Debt S + 2.75% $14,844 14,733 14,920 0.06%
Time Manufacturing Company Machinery 1st Lien Senior Secured Debt E + 6.50% €13,148 14,438 12,351 0.05%
Time Manufacturing Company Machinery 1st Lien Senior Secured Debt S + 6.50% $13,091 13,025 10,732 0.05%
Advarra Holdings, Inc. (Advarra, Inc.) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 4.50% $197,602 196,273 197,602 0.85%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Life Sciences Tools & Services 1st Lien Senior Secured Debt E + 5.25% €62,182 64,648 68,961 0.30%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 5.25% $119,222 105,531 103,217 0.45%
Cambrex Corporation Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 4.75% $42,457 37,854 37,381 0.16%
PerkinElmer U.S. LLC (PerkinElmer) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 4.50% $261,387 258,477 259,459 1.12%
Phantom Purchaser Inc (Pharmacord LLC) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 4.75% $110,583 94,140 93,772 0.41%
WCG Intermediate Corp (WCG) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 2.75% $7,589 7,589 7,567 0.03%
HLEND Societas JV, LLC Investments in Joint Ventures Joint Ventures $116,667 43,750 43,870 0.19%
ULTRA III, LLC (Unitranche Holdings III, LLC) Investments in Joint Ventures Joint Ventures $749,803 407,056 396,920 1.72%
Arches Buyer Inc (Ancestry.com Inc.) Interactive Media & Services 1st Lien Senior Secured Debt S + 4.25% $9,940 9,791 9,801 0.04%
Aurelia Netherlands Midco 2 B.V. (Adevinta ASA) Interactive Media & Services 1st Lien Senior Secured Debt E + 4.75% €125,373 137,950 143,080 0.62%
Cadillac Bidco S.À R.L. (Adevinta Spain SL) Interactive Media & Services 1st Lien Senior Secured Debt E + 4.75% €43,415 51,063 49,271 0.21%

Showing 176 to 200 of 484 entries

Engage with HLEND

Start Here

Footnotes

  1. Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts and less any annual amortization of premiums, as applicable, on accruing (i) debt and (ii) other income producing securities, divided by (b) total accruing (i) debt and (ii) other income producing securities (at fair value). Actual yields earned over the life of each investment could differ materially from the yields presented above. Please refer to HLEND’s prospectus and filings, including Form 10-Q or Form 10-K for fair value disclosures.
  2. Private Investments represents level 3 investments in the investment portfolio where inputs to the valuation methodology are unobservable and significant to overall fair value measurement. Private investments includes investments in joint ventures.
  3. Based on the aggregate fair value of the investment portfolio as of July 31, 2026.
  4. Percentage based on aggregate fair value of performing debt and other income producing securities (excluding investments in joint ventures).
  5. Calculated with respect to all level 3 investments (or, with respect to weighted average loan to value, all level 3 debt investments) in the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment adviser of HLEND, with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets and investments in joint ventures. In the case of weighted average EBITDA only, excludes investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of the original investment thesis, such as loan-to-value-based loans, NAV-based loans or reorganized equity. Weighted average EBITDA is weighted based on the fair value of the total applicable level 3 investments. Loan to value is calculated as net debt through each respective investment tranche in which HLEND holds an investment divided by enterprise value or value of underlying collateral of the portfolio company. Weighted average loan to value is weighted based on the fair value of the total applicable level 3 debt investments. Excludes investments on non-accrual status as of October 31, 2024. Figures are derived from the most recent financial statements from portfolio companies.
  6. Includes “last out” portions of first lien senior secured loans.
  7. Secured debt at the holding company level.
  8. Based on MSCI / S&P Global Industry Classification Standard (“GICS”) industry definition. Totals may not sum due to rounding. 
  9. All figures are as of July 31, 2026 unless otherwise indicated. % of total portfolio shown above is measured as total fair value of investments.
  10. Other includes structured finance investments.
  11. Contractual rates on preferred equity investments may represent preference accruals that are not recognized through investment income of the fund and as such are not included in the calculation of yield. The fair value of these investments may be influenced by the stated preference accrual or a minimum return threshold.

Important Notice

This site and the materials herein are directed only to certain types of investors and to persons in jurisdictions where HPS Corporate Lending Fund (“HLEND”) is authorized for distribution.

Complete information about investing in shares of HLEND is available in the prospectus. An investment in HLEND involves risks.

Download Prospectus

I acknowledge that (i) I have received the Prospectus and (ii) either (a) I am a United States resident or (b) I have otherwise received authorization from HLEND or my broker-dealer/registered investment advisor to access the contents of this website.

By selecting a country or state from the above list, you certify that you are resident in that country or state.

Leave Site